Fluvoxamine monotherapy for psychotic depression: the potential role of sigma-1 receptors

BACKGROUND: Psychotic depression is a clinical subtype of major depressive disorder. A number of clinical studies have demonstrated the efficacy of the combination of an antidepressant (for example, a tricyclic antidepressant or selective serotonin reuptake inhibitor (SSRI)) and an atypical antipsyc...

Descripción completa

Detalles Bibliográficos
Autores principales: Furuse, Tsutomu, Hashimoto, Kenji
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Case report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2803775/
https://www.ncbi.nlm.nih.gov/pubmed/20025739
http://dx.doi.org/10.1186/1744-859X-8-26

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2803775/
https://www.ncbi.nlm.nih.gov/pubmed/20025739
http://dx.doi.org/10.1186/1744-859X-8-26

Ejemplares similares